Na tej stronie
DNA Klasa A Ginkgo Bioworks Holdings, Inc. Class A Common Stock
NYSE · Life Sciences Tools & Services · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 6, 2026
$12,35
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$5,3752tyg. minimum
$17,5852tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$787M
P/E
-2.3
EPS
$-5.64
Przychody
$170M
Twoje odznaki
Zakres 52 tyg.
$5–$18
Ocena Analityków
SELL
Cena Docelowa
$7
P/E
-2.3
ROE
-55.8%
Marża Zysku Netto
-260.0%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
DNA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$12.35
Kapitalizacja Rynkowa (MRQ)
$787M
P/E
-2.3
EPS
$-5.64
Przychody
$170M
ROE
-55.8%
Zakres 52 tyg.
$5–$18
DNA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Podziały akcji
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 20 sierpnia 2024 | 1-for-40 | Odwrotny |
O Ginkgo Bioworks Holdings, Inc. Class A Common Stock Przegląd firmy z Wikipedii
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.
History
In 2014, Ginkgo was the first biotechnology company to join the Y Combinator start-up accelerator program.
On 16 December 2020, it was reported that Ginkgo Bioworks would acquire the primary assets of Novogy's Microbial Engineering Platform. 2020 also saw the company acquire property worth $25 million from Marcus Partners for the construction of a new 219,000 square foot laboratory building, after razing existing structures, located in the Raymond L Flynn Marine Park. As of 2021, the company also occupied 200,000 square feet of the Innovation and Design Building (aka IDB) in the Park. Ginkgo also occupied facilities in Cambridge, where most MIT-spin outs resided at the time.
Growth of Ginkgo up to 2021 had been driven by "robust venture capital funding" and entry into the COVID-19 testing market. This included $45 million from Viking Global in 2015.
On 11 May 2021, Ginkgo Bioworks announced plans of going public through a merger with SPAC Soaring Eagle at a $17.5 billion valuation.
On 14 May 2021, Ginkgo announced its new ticker for the NYSE will be "DNA". The ticker was previously used by Genentech, who stopped using the ticker after they were acquired by Roche. Trading began on September 17, 2021. The investment management firm Baillie Gifford became the largest shareholder (15%) with the purchase of 167.75 million shares on 31 March 2022.
On 14 March 2022, it was reported that Ginkgo Bioworks signed a Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform.
On 6 June 2022, it was reported that Ginkgo Bioworks has acquired assets from real-time metabolite monitoring company, Bitome.
On 25 July 2022, Ginkgo Bioworks agreed to acquire Zymergen for $300 million in an all-stock deal.
On 27 July 2022, it was reported that Ginkgo Bioworks would acquire Bayer's Biologics Research & Development site, located in West Sacramento. Ginkgo will enter into a new multi-year platform collaboration with Bayer. The deal includes the integration of the R&D platform assets from Joyn Bio, a joint-venture between Leaps by Bayer investments and Ginkgo Bioworks.
On 4 October 2022, it was reported that Ginkgo Bioworks would acquire France-based adaptive laboratory evolution instruments developer Altar and California-based Circularis to strengthen capabilities in cell and gene therapy.
In October 2022, Bloomberg News reported that Ginkgo Bioworks partnered with Intelligence Advanced Research Projects Activity to create a software tool to help detect when biological organisms have been genetically engineered. The tool known as ENDAR (short for Engineered Nucleotide Detection and Ranking) could be used to provide an early warning of bioweapons and other man-made biological threats.
Fraud allegations
On 6 October 2021, a market research firm published a report accusing Ginkgo of embellishing its revenue in a complex scheme highly dependent on related-party transactions. The report prompted an inquiry into Ginkgo by the United States Department of Justice. In November 2021, Ginkgo was sued in a shareholder lawsuit alleging it misrepresented its revenue sources in statements regarding its merger with a special-purpose acquisition company. As of 2021, the company could not name a single significant product that is manufactured and sold using its organisms.
In March 2023, the former Attorney General of Louisiana launched an investigation into the officers and directors of Ginkgo.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
sektorHealthcare
branżaLife Sciences Tools & Services
pracownicy485
krajUS
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$170M2019-12-31 → 2025-12-31
EPS$-5.642019-12-31 → 2025-12-31
Wolny przepływ pieniężny$-179M2022-12-31 → 2025-12-31
Marża netto-260.0%2022-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | DNA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E | -2.3średnia z 5 lat ≈-49.3 | ≈-49.3 | · | · | |
| P/S (TTM) | 7.0średnia z 5 lat ≈202.7 | ≈202.7 | · | · | |
| P/B (MRQ) | 1.9średnia z 5 lat ≈49.7 | ≈49.7 | · | · | |
| Cena / FCF (TTM) | -4.5średnia z 5 lat ≈-206.6 | ≈-206.6 | · | · | |
| Cena / Przepływy pieniężne (TTM) | -4.6średnia z 5 lat ≈-242.4 | ≈-242.4 | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | 2.1średnia z 5 lat ≈115.0 | ≈115.0 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | DNA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | -259.9%średnia z 5 lat ≈-309.5% | ≈-309.5% | · | · | |
| EBITDA Margin (Marża EBITDA) | -185.3%średnia z 5 lat ≈-309.5% | ≈-309.5% | · | · | |
| Marża przed opodatkowaniem (TTM) | -264.1%średnia z 5 lat ≈-306.2% | ≈-306.2% | · | · | |
| Marża Zysku Netto (TTM) | -260.0%średnia z 5 lat ≈-305.1% | ≈-305.1% | · | · | |
| ROA | -25.1%średnia z 5 lat ≈-48.7% | ≈-48.7% | · | · | |
| ROE | -55.8%średnia z 5 lat ≈-84.1% | ≈-84.1% | · | · | |
| ROIC | -61.8%średnia z 5 lat ≈-86.3% | ≈-86.3% | · | · |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | DNA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 4.6średnia z 5 lat ≈6.3 | ≈6.3 | · | · | |
| Quick Ratio (Wskaźnik Szybkości) | 4.7średnia z 5 lat ≈6.0 | ≈6.0 | · | · |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | DNA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | -25.1%średnia z 5 lat ≈55.9% | ≈55.9% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | -29.1%średnia z 5 lat ≈3.1% | ≈3.1% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 17.3% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | DNA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.1średnia z 5 lat ≈0.2 | ≈0.2 | · | · | |
| Receivables Turnover (Rotacja należności) | 7.4średnia z 5 lat ≈7.2 | ≈7.2 | · | · | |
| Revenue / Employee (Przychody / pracownika) | ≈$350.8K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
2.6%
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | $-0.75 | $-0.92 | 18.4% | |
| 31 marca 2026 | $-1.39 | $-1.09 | -27.4% | |
| 31 grudnia 2025 | $-1.41 | $-1.47 | 4.1% | |
| 30 września 2025 | $-1.45 | $-1.25 | -15.8% | |
| 30 czerwca 2025 | $-1.10 | $-1.58 | 30.5% | |
| 31 marca 2025 | $-1.68 | $-1.79 | 6.0% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $170M | $227M | $251M | $478M | $314M | $77M | $54M | |
| R&D Expense | $244M | $424M | $581M | $1.05B | $1.15B | $160M | $96M | |
| SG&A Expense | $183M | $246M | $385M | $1.43B | $863M | $38M | $29M | |
| Operating Expenses | $485M | $787M | $1.12B | $2.69B | $2.14B | $214M | $126M | |
| Operating Income | $-315M | $-560M | $-864M | $-2.21B | $-1.83B | $-137M | $-72M | |
| Interest Expense | · | · | $93.0K | $106.0K | $2M | $2M | $2M | |
| Other Non-op | $2M | $12M | $-29M | $88M | $-10M | $12M | · | |
| Pretax Income | $-314M | $-548M | $-893M | $-2.12B | $-1.84B | $-125M | $-120M | |
| Income Tax | $-837.0K | $-479.0K | $-71.0K | $-15M | $-1M | $2M | $22.0K | |
| Net Income | $-313M | $-547M | $-893M | $-2.10B | $-1.83B | $-127M | $-119M | |
| EPS (Basic) | $-5.64 | $-10.54 | $-18.37 | $-50.15 | $-1.35 | $-0.10 | $-0.10 | |
| EPS (Diluted) | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 | $-0.10 | $-0.10 | |
| Shares (Basic) | 55,457,676 | 51,894,639 | 48,610,507 | 41,976,537 | 1,359,849,000 | 1,274,766,915 | 1,149,000,417 | |
| Shares (Diluted) | 55,457,676 | 51,894,639 | 48,610,507 | 41,995,972 | 1,360,373,000 | 1,274,766,915 | 1,149,000,417 | |
| EBITDA | $-315M | $-560M | $-864M | $-2.21B | · | · | · |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $167M | $562M | $944M | $1.32B | $1.55B | $381M | $495M | |
| Short-term Investments | $255M | $0 | · | · | · | · | · | |
| Receivables | $24M | $22M | $17M | $81M | $132M | $17M | · | |
| Inventory | · | · | $46.0K | $4M | $3M | $3M | · | |
| Prepaid Expense | $25M | $19M | $40M | $52M | $34M | $21M | · | |
| Other Current Assets | · | · | $362.0K | $487.0K | $698.0K | $680.0K | · | |
| Current Assets | $472M | $603M | $1.00B | $1.45B | $1.72B | $427M | · | |
| PP&E (Net) | $167M | $204M | $188M | $315M | $146M | $121M | · | |
| PP&E (Gross) | $355M | $365M | $309M | $408M | $207M | $155M | · | |
| Accum. Depreciation | $188M | $161M | $121M | $93M | $61M | $34M | · | |
| Goodwill | · | $0 | $49M | $60M | $21M | $2M | $2M | |
| Intangibles | $53M | $73M | $83M | $111M | $22M | $3M | · | |
| Other Non-current Assets | $9M | $55M | $58M | $89M | $44M | $6M | · | |
| Total Assets | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B | $675M | · | |
| Accounts Payable | $11M | $14M | $9M | $10M | $8M | $14M | · | |
| Accrued Liabilities | · | · | · | $115M | $93M | $31M | · | |
| Short-term Debt | · | · | · | · | · | $300.0K | · | |
| Current Liabilities | $96M | $107M | $164M | $173M | $135M | $73M | · | |
| Capital Leases | $417M | $439M | $222M | $413M | $0 | · | · | |
| Other Non-current Liabilities | $23M | $17M | $24M | $31M | $36M | $3M | · | |
| Total Liabilities | $611M | $661M | $568M | $803M | $504M | $205M | · | |
| Common Stock | $6.0K | $5.0K | $5.0K | $190.0K | $161.0K | $129.0K | · | |
| Paid-in Capital | $6.66B | $6.56B | $6.39B | $6.14B | $3.80B | $929M | · | |
| Retained Earnings | $-6.15B | $-5.84B | $-5.29B | $-4.40B | $-2.30B | $-468M | · | |
| AOCI | $2M | $-2M | $1M | $-3M | $-2M | $0 | · | |
| Stockholders' Equity | $509M | $716M | $1.10B | $1.74B | $1.57B | $470M | · | |
| Liabilities + Equity | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B | $675M | · | |
| Shares Outstanding | 58,207,298 | 54,365,785,000 | 50,032,873 | 47,299,399 | 40,284,804 | 1,288,596,000 | · |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $59M | $63M | $71M | $43M | $29M | $14M | $11M | |
| Stock-based Comp | $82M | $112M | $230M | $1.93B | $1.61B | $476.0K | $771.0K | |
| Deferred Tax | $-1M | $-936.0K | $-801.0K | $-15M | $0 | $0 | · | |
| Amort. of Intangibles | $19M | $18M | $16M | $6M | $1M | $500.0K | $500.0K | |
| Restructuring | $11M | $19M | · | · | · | · | · | |
| Operating Cash Flow | $-171M | $-320M | $-296M | $-252M | $-254M | $-136M | $-45M | |
| CapEx | $8M | $63M | $41M | $52M | $57M | $58M | $22M | |
| Investing Cash Flow | $-240M | $-62M | $-81M | $-67M | $-73M | $-67M | $-75M | |
| Stock Issued | $19M | $0 | $0 | · | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | $408.0K | |
| Net Stock Activity | $19M | · | · | · | · | · | · | |
| Financing Cash Flow | $18M | $-2M | $-3M | $95M | $1.53B | $90M | $410M | |
| Net Change in Cash | $-393M | $-384M | $-380M | $-223M | $1.21B | $-113M | $291M | |
| Taxes Paid | $192.0K | $0 | $23.0K | $981.0K | $9M | $0 | · | |
| Free Cash Flow | $-179M | $-382M | $-336M | $-304M | · | · | · | |
| Levered FCF | · | · | $-336M | $-305M | · | · | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -185.3% | -246.5% | -343.8% | -462.4% | · | · | · | |
| Net Margin | -183.8% | -240.9% | -355.1% | -440.6% | · | · | · | |
| Pretax Margin | -184.3% | -241.2% | -355.1% | -444.1% | · | · | · | |
| EBITDA Margin | -185.3% | -246.5% | -343.8% | -462.4% | · | · | · | |
| ROA | -25.1% | -36.0% | -42.5% | -91.3% | · | · | · | |
| ROE | -55.8% | -72.3% | -76.0% | -132.4% | · | · | · | |
| ROIC | -61.8% | -78.1% | -78.8% | -126.3% | · | · | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 5.6 | 6.1 | 8.4 | · | · | · | |
| Quick Ratio | 4.7 | 5.4 | 5.9 | 8.1 | · | · | · | |
| Interest Coverage | · | · | -9294.7 | -20839.2 | · | · | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | 0.2 | · | · | · | |
| Receivables Turnover | 7.4 | 11.6 | 5.1 | 4.5 | · | · | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.74 | $13.17 | $0.55 | $0.92 | · | · | · | |
| Revenue / Share | $3.07 | $4.38 | $0.13 | $0.28 | · | · | · | |
| Cash Flow / Share | $-3.08 | $-6.16 | $-0.15 | $-0.15 | · | · | · | |
| Cash / Share | $2.87 | $10.33 | $0.47 | $0.70 | · | · | · | |
| EPS (TTM) | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 | · | · |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -25.1% | -9.7% | -47.4% | 52.2% | 309.4% | · | · | |
| Revenue CAGR 3Y | -29.1% | -10.2% | 48.6% | · | · | · | · | |
| Revenue CAGR 5Y | 17.3% | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $170M | $227M | $251M | $478M | $314M | · | · | |
| Net Income TTM | $-313M | $-547M | $-893M | $-2.10B | $-1.83B | · | · | |
| Market Cap | $484M | $534M | $135.29B | $127.90B | · | · | · | |
| P/E | -1.5 | -0.9 | -3.7 | -1.3 | -239.1 | · | · | |
| P/S | 2.8 | 2.4 | 538.0 | 267.7 | · | · | · | |
| P/B | 1.0 | 0.7 | 123.3 | 73.7 | · | · | · | |
| P / Tangible Book | 1.1 | 0.8 | 140.2 | 81.7 | 351.4 | · | · | |
| P / Cash Flow | -2.8 | -1.7 | -457.8 | -507.1 | · | · | · | |
| P / FCF | -2.7 | -1.4 | -402.3 | -420.1 | · | · | · | |
| Earnings Yield | -67.9% | -107.3% | -27.2% | -74.3% | -0.42% | · | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20M | $19M | $33M | $39M | $39M | $38M | $44M | $89M | $56M | $38M | $35M | $55M | $81M | $81M | $98M | $66M | |
| Cost of Revenue | $2M | $3M | · | · | $5M | $4M | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $46M | $50M | $50M | $69M | $53M | $71M | $76M | $77M | $134M | $136M | $117M | $157M | $144M | $163M | $178M | $261M | |
| SG&A Expense | $31M | $38M | $46M | $45M | $35M | $40M | $57M | $52M | $66M | $70M | $89M | $82M | $102M | $111M | $121M | $435M | |
| Operating Expenses | $79M | $91M | $104M | $129M | $97M | $119M | $147M | $144M | $279M | $216M | $213M | $342M | $265M | $296M | $329M | $721M | |
| Operating Income | $-59M | $-71M | $-71M | $-90M | $-58M | $-81M | $-104M | $-55M | $-223M | $-178M | $-178M | $-286M | $-184M | $-216M | $-231M | $-655M | |
| Other Non-op | $1M | $-5M | $-11M | $9M | $5M | $-2M | $-4M | $-2M | $6M | $12M | $-34M | $-17M | $11M | $11M | $43M | $-15M | |
| Pretax Income | $-57M | $-76M | $-81M | $-81M | $-53M | $-83M | $-108M | $-57M | $-217M | $-166M | $-212M | $-303M | $-173M | $-205M | $-188M | $-670M | |
| Income Tax | $128.0K | $-80.0K | $-643.0K | $1.0K | $-283.0K | $88.0K | $-325.0K | $-375.0K | $190.0K | $31.0K | $-198.0K | $-22.0K | $67.0K | $82.0K | $-15M | $-28.0K | |
| Net Income | $-47M | $-83M | $-81M | $-81M | $-60M | $-91M | $-108M | $-56M | $-217M | $-166M | $-212M | $-303M | $-173M | $-205M | $-175M | $-670M | |
| EPS (Basic) | $-0.75 | $-1.39 | $-1.41 | $-1.45 | $-1.10 | $-1.68 | $-1.92 | $-1.08 | $-4.23 | $-3.31 | $-11.96 | $-6.21 | $-0.09 | $-0.11 | $-48.96 | $-0.41 | |
| EPS (Diluted) | · | · | $-1.41 | $-1.45 | $-1.10 | $-1.68 | $-1.91 | $-1.08 | $-4.23 | $-3.32 | $-11.96 | $-6.21 | $-0.09 | $-0.11 | $-49.01 | $-0.41 | |
| Shares (Basic) | 62,094,356 | 59,563,454 | · | 55,633,718 | 54,858,982 | 54,241,619 | · | 52,240,559 | 51,370,029 | 50,111,460 | · | 48,770,000 | 1,933,437,000 | 1,914,963,000 | · | 1,630,911,000 | |
| Shares (Diluted) | · | · | · | 55,633,718 | 54,858,982 | 54,241,619 | · | 52,246,129 | 51,375,599 | 50,133,366 | · | 48,770,000 | 1,933,437,000 | 1,916,637,000 | · | 1,630,911,000 | |
| EBITDA | $-59M | $-71M | · | $-90M | $-66M | $-89M | · | $-55M | $-223M | $-178M | · | $-286M | $-184M | $-216M | · | $-653M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $144M | $167M | $111M | $204M | $312M | $562M | $616M | $730M | $840M | $944M | $1.05B | $1.11B | $1.21B | $1.32B | $1.30B | |
| Short-term Investments | · | · | $255M | $384M | $356M | $13M | $0 | · | · | · | · | · | · | · | · | · | |
| Receivables | $13M | $20M | $24M | $21M | $22M | $26M | $22M | $23M | $19M | $24M | · | $62M | $68M | $83M | · | $114M | |
| Inventory | · | · | · | · | · | · | · | · | · | · | · | $70.0K | $391.0K | $3M | · | $6M | |
| Prepaid Expense | $17M | $16M | $25M | $22M | $26M | $20M | $19M | $22M | $34M | $38M | · | $29M | $48M | $34M | · | $38M | |
| Current Assets | $333M | $410M | $472M | $506M | $523M | $565M | $603M | $662M | $783M | $903M | · | $1.14B | $1.22B | $1.33B | · | $1.46B | |
| PP&E (Net) | $157M | $163M | $168M | $177M | $186M | $198M | $204M | $211M | $211M | $196M | · | $202M | $294M | $314M | · | $188M | |
| PP&E (Gross) | $355M | $352M | $358M | $359M | $360M | $361M | $365M | $362M | $347M | $326M | · | $322M | $413M | $421M | · | $271M | |
| Accum. Depreciation | $198M | $189M | $191M | $182M | $173M | $163M | $161M | $151M | $136M | $130M | · | $121M | $118M | $107M | · | $83M | |
| Goodwill | · | · | · | · | · | · | $0 | $0 | $0 | $48M | $49M | $58M | $59M | $59M | $60M | $29M | |
| Intangibles | $44M | $49M | $57M | $62M | $66M | $69M | $73M | $80M | $91M | $77M | · | $100M | $105M | $109M | · | $48M | |
| Other Non-current Assets | $1M | $40M | $47M | $47M | $47M | $47M | $55M | $60M | $60M | $61M | · | $97M | $98M | $97M | · | $44M | |
| Total Assets | $990M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B | $1.63B | $1.58B | · | $2.03B | $2.29B | $2.42B | · | $1.87B | |
| Accounts Payable | $10M | $16M | $11M | $11M | $11M | $11M | $14M | $16M | $23M | $27M | · | $11M | $14M | $22M | · | $11M | |
| Current Liabilities | $73M | $80M | $96M | $115M | $97M | $116M | $107M | $114M | $166M | $169M | · | $168M | $163M | $192M | · | $125M | |
| Capital Leases | $404M | $411M | $417M | $423M | $429M | $435M | $439M | $446M | $452M | $234M | · | $404M | $411M | $404M | · | · | |
| Other Non-current Liabilities | $16M | $22M | $23M | $17M | $18M | $15M | $17M | $18M | $21M | $25M | · | $19M | $20M | $29M | · | $35M | |
| Total Liabilities | $570M | $590M | $611M | $629M | $618M | $646M | $661M | $683M | $792M | $594M | · | $774M | $788M | $810M | · | $431M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $206.0K | $202.0K | · | $198.0K | $196.0K | $194.0K | · | $165.0K | |
| Paid-in Capital | $6.70B | $6.67B | $6.66B | $6.63B | $6.60B | $6.58B | $6.56B | $6.53B | $6.51B | $6.45B | · | $6.33B | $6.28B | $6.21B | · | $5.67B | |
| Retained Earnings | $-6.28B | $-6.23B | $-6.15B | $-6.07B | $-5.99B | $-5.93B | $-5.84B | $-5.73B | $-5.67B | $-5.46B | · | $-5.08B | $-4.78B | $-4.60B | · | $-4.23B | |
| AOCI | $950.0K | $1M | $2M | $2M | $2M | $-850.0K | $-2M | $263.0K | $-2M | $-2M | · | $-3M | $-1M | $-2M | · | $-8M | |
| Stockholders' Equity | $420M | $443M | $509M | $560M | $613M | $647M | $716M | $798M | $833M | $987M | $1.10B | $1.25B | $1.50B | $1.61B | $1.74B | $1.43B | |
| Liabilities + Equity | $990M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B | $1.63B | $1.58B | · | $2.03B | $2.29B | $2.42B | · | $1.87B | |
| Shares Outstanding | 63,711,102 | 61,660,788 | 58,207,298 | 56,836,246 | 55,425,334 | 54,698,246 | 54,365,785 | 53,082,000 | 2,078,737,000 | 2,033,624,000 | 50,032,873 | 1,972,725,000 | 1,954,704,000 | 1,933,880,000 | 47,299,399 | 1,648,263,224 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $13M | $14M | $14M | $16M | $15M | $16M | $17M | $17M | $13M | $13M | $21M | $18M | $19M | $16M | $8M | |
| Stock-based Comp | $8M | $16M | $21M | $18M | $22M | $17M | $21M | $14M | $37M | $41M | $43M | $53M | $61M | $73M | $108M | $563M | |
| Amort. of Intangibles | $4M | $4M | $5M | $5M | $4M | $4M | $5M | $5M | $5M | $3M | $3M | $4M | $4M | $4M | $3M | $1M | |
| Restructuring | · | · | $706.0K | $2M | $4M | · | $-666.0K | $3M | $12M | · | · | $0 | $0 | · | · | · | |
| Operating Cash Flow | $-44M | $-47M | $-48M | $-32M | $-40M | $-52M | $-42M | $-104M | $-84M | $-89M | $-58M | $-74M | $-74M | $-91M | $-105M | $-28M | |
| CapEx | $3M | $2M | $5.0K | $0 | $38.0K | $8M | $14M | $15M | $27M | $7M | $3M | $4M | $14M | $19M | $26M | $13M | |
| Investing Cash Flow | $11M | $23M | $95M | $-73M | $-64M | $-199M | $-13M | $-10M | $-27M | $-12M | $-47M | $-3M | $-11M | $-19M | $30M | $-46M | |
| Stock Issued | · | · | $9M | $10M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $16M | $-19.0K | $8M | $10M | $-98.0K | $-207.0K | $-203.0K | $-465.0K | $-226.0K | $-845.0K | $-632.0K | $-315.0K | $-1M | $-888.0K | $98M | $-280.0K | |
| Net Change in Cash | $-17M | $-24M | $55M | $-94M | $-104M | $-250M | $-56M | $-114M | $-111M | $-102M | $-105M | $-77M | $-87M | $-111M | $24M | $-75M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Free Cash Flow | · | $-49M | · | · | · | $-59M | · | · | · | $-96M | · | · | · | $-110M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -290.5% | -366.5% | · | -231.8% | -132.1% | -184.1% | · | -62.0% | -396.7% | -469.1% | · | -516.7% | -228.6% | -267.3% | · | -983.5% | |
| Net Margin | -231.7% | -424.1% | · | -207.9% | -121.6% | -188.2% | · | -63.3% | -386.4% | -437.2% | · | -546.4% | -215.1% | -254.0% | · | -1007.6% | |
| Pretax Margin | -283.8% | -391.0% | · | -207.9% | -122.1% | -188.1% | · | -63.8% | -386.1% | -437.2% | · | -546.5% | -215.0% | -253.9% | · | -1007.7% | |
| EBITDA Margin | -290.5% | -366.5% | · | -231.8% | -132.1% | -184.1% | · | -62.0% | -396.7% | -469.1% | · | -516.7% | -228.6% | -267.3% | · | -983.5% | |
| ROA | -4.2% | -7.1% | · | -6.0% | -4.2% | -6.3% | · | -3.2% | -11.1% | -8.3% | · | -15.5% | -8.1% | -9.2% | · | -33.3% | |
| ROE | -9.0% | -15.2% | · | -11.9% | -8.3% | -11.1% | · | -5.5% | -18.6% | -12.8% | · | -22.5% | -11.4% | -12.9% | · | -44.8% | |
| ROIC | -14.0% | -16.1% | · | -16.1% | -10.6% | -13.8% | · | -6.9% | -26.8% | -18.0% | · | -22.9% | -12.2% | -13.4% | · | -45.5% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 5.2 | · | 4.4 | 5.4 | 4.9 | · | 5.8 | 4.7 | 5.3 | · | 6.8 | 7.5 | 6.9 | · | 11.7 | |
| Quick Ratio | 1.3 | 2.1 | · | 4.5 | 6.0 | 3.0 | · | 5.6 | 4.5 | 5.1 | · | 6.6 | 7.2 | 6.7 | · | 11.3 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 1.1 | 0.8 | · | 1.7 | 2.4 | 1.9 | · | 2.1 | 1.3 | 0.7 | · | 0.6 | 0.7 | 0.6 | · | 0.8 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.60 | $7.19 | · | $9.85 | $11.06 | $11.84 | · | $15.03 | $0.40 | $0.49 | · | $0.64 | $0.77 | $0.83 | · | $0.87 | |
| Revenue / Share | · | · | · | $0.70 | $0.90 | $0.89 | · | $1.70 | $0.03 | $0.02 | · | $0.03 | $0.04 | $42.11 | · | $0.04 | |
| Cash Flow / Share | · | · | · | · | · | $-0.95 | · | · | · | $-0.04 | · | · | · | $-47.26 | · | · | |
| Cash / Share | $1.33 | $2.33 | · | $1.95 | $3.67 | $5.71 | · | $11.61 | $0.35 | $0.41 | · | $0.53 | $0.57 | $0.62 | · | $0.79 | |
| EPS (TTM) | $-5.64 | $-5.64 | · | $-6.14 | $-5.77 | $-8.90 | · | $-20.59 | $-25.72 | $-21.58 | · | $-55.42 | $-49.62 | $-49.94 | · | $-2.40 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $112M | $131M | · | $160M | $210M | $227M | · | $218M | $184M | $209M | · | $315M | $326M | $390M | · | $528M | |
| Net Income TTM | $-291M | $-304M | · | $-340M | $-315M | $-472M | · | $-651M | $-898M | $-854M | · | $-857M | $-1.22B | $-1.72B | · | $-3.53B | |
| Market Cap | $631M | $378M | · | $829M | $624M | $312M | · | $433M | $27.77B | $94.36B | · | $142.83B | $145.43B | $102.88B | · | $205.70B | |
| P/E | -1.8 | -1.1 | · | -2.4 | -1.9 | -0.6 | · | -0.4 | -0.5 | -2.2 | · | -1.3 | -1.5 | -1.1 | · | -52.0 | |
| P/S | 5.6 | 2.9 | · | 5.2 | 3.0 | 1.4 | · | 2.0 | 150.7 | 452.1 | · | 453.4 | 446.2 | 263.8 | · | 389.7 | |
| P/B | 1.5 | 0.9 | · | 1.5 | 1.0 | 0.5 | · | 0.5 | 33.3 | 95.6 | · | 114.0 | 96.7 | 64.0 | · | 143.4 | |
| P / Tangible Book | 1.7 | 1.0 | · | 1.7 | 1.1 | 0.5 | · | 0.6 | 37.4 | 109.5 | · | 130.5 | 108.6 | 71.4 | · | 151.5 | |
| P / Cash Flow | · | -8.1 | · | · | · | -6.1 | · | · | · | -1057.2 | · | · | · | -1135.8 | · | · | |
| Earnings Yield | -56.9% | -92.0% | · | -42.1% | -51.3% | -156.1% | · | -252.6% | -192.5% | -46.5% | · | -76.5% | -66.7% | -93.9% | · | -1.9% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $170M | $227M | $251M | $478M | $314M |
| Marża Operacyjna % | -185.3% | -246.5% | -343.8% | -462.4% | · |
| Zysk netto | $-313M | $-547M | $-893M | $-2.10B | $-1.83B |
| Rozwodniony EPS | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 4.9 | 5.6 | 6.1 | 8.4 | · |
| Wskaźnik Szybkości | 4.7 | 5.4 | 5.9 | 8.1 | · |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-179M | $-382M | $-336M | $-304M | · |
Właściciele instytucjonalni (13F) 201 emitentów · $379.7M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
201
Wartość posiadanych akcji
$379.7M
Nowe pozycje
31
Zamknięte pozycje
17
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 31 (-1 vs poprzedni kw.) | 17 (-12 vs poprzedni kw.) | 71 (+18 vs poprzedni kw.) | 37 (-5 vs poprzedni kw.) | +4.5M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $42 443 568 | 4 282 903 | 11,18% | Akcje |
| VIKING GLOBAL INVESTORS LP | $35 449 338 | 3 577 128 | 9,33% | Akcje |
| Erste Asset Management GmbH | $25 902 147 | 2 536 939 | 6,82% | Akcje |
| VANGUARD GROUP INC | $24 106 911 | 2 900 952 | 6,35% | Akcje |
| BAILLIE GIFFORD & CO | $23 701 242 | 2 391 649 | 6,24% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $20 685 074 | 2 087 293 | 5,45% | Akcje |
| Anchorage Capital Group, L.L.C. | $17 306 457 | 1 746 363 | 4,56% | Akcje |
| Legal & General Group Plc | $16 543 944 | 1 669 419 | 4,36% | Akcje |
| STATE STREET CORP | $14 591 187 | 1 472 370 | 3,84% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $12 112 753 | 1 222 016 | 3,19% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9 293 628 | 937 803 | 2,45% | Akcje |
| Allianz Asset Management GmbH | $7 787 258 | 785 798 | 2,05% | Akcje |
| UBS Group AG | $6 854 341 | 691 659 | 1,80% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $6 329 279 | 638 676 | 1,67% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $6 160 304 | 621 625 | 1,62% | Akcje |
| SB INVESTMENT ADVISERS (UK) LTD | $6 052 324 | 610 729 | 1,59% | Akcje |
| GOLDMAN SACHS GROUP INC | $6 019 096 | 607 376 | 1,59% | Akcje |
| BANK OF AMERICA CORP /DE/ | $5 409 393 | 545 852 | 1,42% | Akcje |
| Prescott Group Capital Management, L.L.C. | $5 369 684 | 541 845 | 1,41% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $5 349 973 | 539 856 | 1,41% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4 109 677 | 414 700 | 1,08% | Opcja kupna |
| NORTHERN TRUST CORP | $4 014 948 | 405 141 | 1,06% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3 910 555 | 394 607 | 1,03% | Akcje |
| EXCHANGE TRADED CONCEPTS, LLC | $3 555 540 | 358 783 | 0,94% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $3 480 392 | 351 200 | 0,92% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $3 326 886 | 335 710 | 0,88% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $3 097 598 | 312 573 | 0,82% | Akcje |
| Coastal Bridge Advisors, LLC | $2 743 256 | 276 817 | 0,72% | Akcje |
| Invesco Ltd. | $2 098 175 | 211 723 | 0,55% | Akcje |
| BALANCE CAPITAL PARTNERS L.P. | $1 972 179 | 199 009 | 0,52% | Akcje |
| ALGERT GLOBAL LLC | $1 784 395 | 180 060 | 0,47% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $1 746 449 | 176 231 | 0,46% | Akcje |
| Bank of New York Mellon Corp | $1 689 463 | 170 481 | 0,44% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $1 637 935 | 165 281 | 0,43% | Akcje |
| PEAK6 LLC | $1 619 294 | 163 400 | 0,43% | Opcja kupna |
| CAXTON ASSOCIATES LLP | $1 532 552 | 154 647 | 0,40% | Akcje |
| D. E. Shaw & Co., Inc. | $1 499 938 | 151 356 | 0,39% | Akcje |
| Nuveen, LLC | $1 455 234 | 146 845 | 0,38% | Akcje |
| MORGAN STANLEY | $1 430 152 | 144 314 | 0,38% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $1 387 400 | 140 000 | 0,37% | Akcje |
| JPMORGAN CHASE & CO | $1 368 548 | 134 040 | 0,36% | Akcje |
| CITADEL ADVISORS LLC | $1 297 565 | 130 935 | 0,34% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 297 219 | 130 900 | 0,34% | Opcja sprzedaży |
| a16z Capital Management, L.L.C. | $1 075 909 | 108 568 | 0,28% | Akcje |
| CITADEL ADVISORS LLC | $1 073 253 | 108 300 | 0,28% | Opcja kupna |
| Numerai GP LLC | $1 036 606 | 104 602 | 0,27% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $974 718 | 98 357 | 0,26% | Akcje |
| WOLVERINE TRADING, LLC | $964 467 | 72 900 | 0,25% | Opcja kupna |
| Ensign Peak Advisors, Inc | $931 332 | 93 979 | 0,25% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $803 592 | 81 089 | 0,21% | Akcje |
Aktywiści i właściciele 5%+ 4 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Reshma P. Shetty, Barry Canton | 14 lutego 2025 | 9,50% | Aneks | · | SEC |
| Jason Kelly ×4 zgłoszenia | 14 lutego 2024 | · | Pierwotne zgłoszenie | · | SEC |
| Reshma Shetty, Bartholomew Canton ×4 zgłoszenia | 14 lutego 2024 | · | Pierwotne zgłoszenie | · | SEC |
| VIKING GLOBAL INVESTORS LP, VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, O. ANDREAS HALVORSEN, DAVID C. OTT, ROSE S. SHABET ×3 zgłoszenia | 4 marca 2022 | · | Pierwotne zgłoszenie | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 17 insiderów · 5 dyrektorzy generalni · 13 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jason R Kelly | Chief Executive Officer & Founder | 28 lipca 2026 A | 316 483 | 0 | 2 | $-1 374 823 |
| Steven P. Coen | Chief Financial Officer | 21 sierpnia 2026 M | 51 851 | 0 | 10 | $-348 032 |
| Mark E. Dmytruk | Chief Financial Officer | 20 maja 2025 M | 46 226 | 0 | 0 | $0 |
| Reshma P. Shetty | President & Founder | 28 lipca 2026 A | 436 422 | 0 | 3 | $-977 101 |
| Marie E. Fallon | Chief Accounting Officer | 1 maja 2023 M | 183 010 | 0 | 0 | $0 |
| Christian O Henry | Dyrektor | 15 września 2026 S | 19 310 | 0 | 1 | $-35 400 |
| Sri Kosuri | Dyrektor | 11 czerwca 2026 A | 24 067 | 0 | 0 | $0 |
| Ross Fubini | Dyrektor | 11 czerwca 2026 A | 10 822 | 0 | 0 | $0 |
| Harry Sloan | Dyrektor | 11 czerwca 2026 A | 271 418 | 0 | 0 | $0 |
| Shyam Sankar | Dyrektor | 12 czerwca 2025 A | 72 372 | 0 | 0 | $0 |
| Kathy Hopinkah Hannan | Dyrektor | 11 czerwca 2025 M | 15 003 | 0 | 0 | $0 |
| Myrtle S Potter | Dyrektor | 11 czerwca 2025 M | 10 822 | 0 | 0 | $0 |
| Arie Belldegrun | Dyrektor | 13 czerwca 2024 A | 194 925 | 0 | 0 | $0 |
| Reshma Kewalramani | Dyrektor | 12 czerwca 2024 M | 186 002 | 0 | 0 | $0 |
| Marijn E Dekkers | Dyrektor | 12 czerwca 2024 M | 386 480 | 0 | 0 | $0 |
| Eagle Equity Partners III, LLC | Dyrektor | 16 września 2021 D | 31 590 948 | 0 | 0 | $0 |
| Barry Canton | Posiadacz 10% | 28 lipca 2026 A | 436 422 | 0 | 3 | $-977 101 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 25 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| THNQ · EXCHANGE TRADED CONCEPTS TRUST | 0,69% | 355 179 NS | 31 lipca 2026 | N-PORT |
| IDNA · iShares Trust | 0,31% | 115 910 SH | 11 września 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 167 123 SH | 1 października 2026 | Dziennie |
| IWC · iShares Trust | 0,08% | 160 915 SH | 11 września 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 41 498 SH | 19 sierpnia 2026 | Dziennie |
| IBB · iShares Trust | 0,02% | 379 730 SH | 11 września 2026 | Dziennie |
| RSSL · Global X Funds | 0,01% | 22 732 NS | 31 lipca 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1 228 746 SH | 11 września 2026 | Dziennie |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 549 889 SH | 19 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 274 008 SH | 19 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,01% | 112 735 SH | 19 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,00% | 85 360 NS | 31 lipca 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 2 967 NS | 31 lipca 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,00% | 17 486 NS | 31 lipca 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 4 528 NS | 31 lipca 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0,00% | 324 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4 838 NS | 31 lipca 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 22 370 SH | 3 września 2026 | Dziennie |
| ITOT · iShares Trust | 0,00% | 66 426 SH | 11 września 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,00% | 29 590 NS | 31 lipca 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 5 670 NS | 31 lipca 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 10 065 NS | 31 lipca 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 489 851 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 264 SH | 19 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | · | 443 818 SH | 11 września 2026 | Dziennie |
DNA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 10 analityków
SPRZEDAJ
Średni cel
$7.00
-43,3%
0 0,0%
Mocne kupno
0 0,0%
Kup
3 30,0%
Trzymaj
5 50,0%
Sprzedaj
2 20,0%
Mocna sprzedaż
12-miesięczny cel cenowy
2 analityków · 2026-10-03Średnia cel $7.00 -43,3%
Powyżej wszystkich celów →
Aktualna cena $12.35
Niski$5.00
Średnia$7.00
Wysoki$9.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| DNA | $484M | -1.5 | -25.1% | -183.8% | -55.8% | · |
| FTRE | $1.61B | -1.6 | 1.0% | -36.2% | -171.1% | · |
| BLFS | · | -241.8 | 28.9% | · | · | · |
| AZTA | $1.32B | -23.5 | 3.5% | -9.4% | -3.3% | 45.5% |
| PSNL | $816M | -8.7 | -17.7% | -116.7% | -36.0% | · |
| CYRX | $479M | 6.9 | 12.4% | 44.4% | 15.3% | 47.1% |
| PACB | $565M | -1.0 | 3.9% | -341.5% | -1634.9% | 28.6% |
| CTKB | $649M | 505.0 | 0.52% | -33.0% | -18.5% | 51.8% |
| MLAB | $489M | 73.1 | 3.4% | 2.7% | 3.7% | 63.5% |
| OABI | · | · | · | · | · | · |
| TKNO | $204M | -11.9 | 7.3% | -42.6% | -23.8% | 33.2% |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
W którą akcję "Wspaniałej Siódemki" teraz inwestuje Cathie Wood
Nasdaq · 2 miesiące temu
Yahoo announces AI-powered experiences for Yahoo Finance and Yahoo Sports
Yahoo Finance · 3 miesiące, 4 tygodnie temu
This Warren Buffett Stock Is Beating the S&P 500 in 2026
Nasdaq · 3 miesiące, 4 tygodnie temu
Prokurator General Kalifornii pozwa następcę 23andMe w związku z naruszeniem danych w 2023 roku
BBC Business · 4 miesiące temu
Zakazy reklam dotyczących zestawów do samodzielnego pobierania wymazów DNA jako wprowadzające w błąd
BBC Business · 4 miesiące, 1 tydzień temu
Jim Cramer o BillionToOne: „Mówię kupuj”
Yahoo Finance · 4 miesiące, 2 tygodnie temu
Jak oparzenie słoneczne zainspirowało nowy sposób magazynowania energii
BBC Business · 4 miesiące, 3 tygodnie temu
Sprzedawcy marihuany pozwani za rzekome nieostrzeganie konsumentów o ryzyku
ZeroHedge · 4 miesiące, 3 tygodnie temu
Wzrost o 30% w 1 miesiąc, czy Zcash jest lepszym zakupem niż Bitcoin?
Yahoo Finance · 5 miesięcy, 1 tydzień temu
SCHQ vs. TLT: Podobny DNA obligacji skarbowych, bardzo różne koszty i okres.
Nasdaq · 5 miesięcy, 2 tygodnie temu
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 6, 2026